MicroRNA‐193a‐5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1
暂无分享,去创建一个
Hui Wang | Ligang Lin | L. Jin | K. Yin | Lingfang Teng | Junyou Wang | Huiyong Li | Da Lin | Gaojun Lin | Yongqiang Zhang | X. Ying | Zheng Lin | Lisong Wang
[1] Xiaoyan Li,et al. Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer , 2020, Cancer management and research.
[2] Yi Pan,et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. , 2020, American journal of cancer research.
[3] Fan Yang,et al. MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin , 2019, OncoTargets and therapy.
[4] S. Ju,et al. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer , 2018, Pathology & Oncology Research.
[5] Xin Yu,et al. NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression , 2018, Journal of cellular and molecular medicine.
[6] Man-Li Zhang,et al. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel , 2017, Journal of experimental & clinical cancer research : CR.
[7] H. Cui,et al. Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway , 2017, International journal of molecular medicine.
[8] Chengzhen Li,et al. NOVA1 acts as an oncogene in osteosarcoma. , 2017, American journal of translational research.
[9] Na Hui,et al. MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers , 2016, Journal of Cancer.
[10] M. Hsiao,et al. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma , 2016, Oncotarget.
[11] S. Cai,et al. MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively , 2016, Clinical & Experimental Metastasis.
[12] R. Qin,et al. High expression of WDR1 in primary glioblastoma is associated with poor prognosis. , 2016, American journal of translational research.
[13] Zhaopei Li,et al. Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells. , 2016, American journal of translational research.
[14] Shuo Gu,et al. Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer , 2015, Cancer Cell International.
[15] B. Shen,et al. MicroRNA‐339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1 , 2015, FEBS letters.
[16] C. Croce,et al. MicroRNA in Cancer and Cachexia--A Mini-Review. , 2015, The Journal of infectious diseases.
[17] You-hong Cui,et al. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma , 2015, Clinical Cancer Research.
[18] K. Reddy,et al. MicroRNA (miRNA) in cancer , 2015, Cancer Cell International.
[19] Xinjian Zhang,et al. Impact of Autophagy Inhibition at Different Stages on Cytotoxic Effect of Autophagy Inducer in Glioblastoma Cells , 2015, Cellular Physiology and Biochemistry.
[20] Xiaowei Wang,et al. miRDB: an online resource for microRNA target prediction and functional annotations , 2014, Nucleic Acids Res..
[21] M. Sammeth,et al. Nova1 is a master regulator of alternative splicing in pancreatic beta cells , 2014, Nucleic acids research.
[22] P. Zhang,et al. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. , 2014, World journal of gastroenterology.
[23] Juan Li,et al. Emerging Role of MicroRNAs in Cancer and Cancer Stem Cells , 2014, Journal of cellular biochemistry.
[24] H. H. Andersen,et al. MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme—a Systematic Overview , 2014, Molecular Neurobiology.
[25] Jing Zhang,et al. MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells , 2014, The Journal of Immunology.
[26] K. Aldape,et al. Using the molecular classification of glioblastoma to inform personalized treatment , 2014, The Journal of pathology.
[27] Anders H. Lund,et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus , 2013, Scientific Reports.
[28] Yun Xiao,et al. Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma. , 2013, Neuro-oncology.
[29] S. Chan,et al. Ineffective delivery of diet-derived microRNAs to recipient animal organisms , 2013, RNA biology.
[30] S. Ying,et al. MicroRNA‐mediated somatic cell reprogramming , 2013, Journal of cellular biochemistry.
[31] Yan Gao,et al. Dynamic Expression Pattern of Neuro-oncological Ventral Antigen 1 (Nova1) in the Rat Brain after Focal Cerebral Ischemia/Reperfusion Insults , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] P. Kleihues,et al. The Definition of Primary and Secondary Glioblastoma , 2012, Clinical Cancer Research.
[33] J. Fak,et al. Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing , 2009, Proceedings of the National Academy of Sciences.
[34] E. Castigli,et al. Expression and Modulation of the Intermediate- Conductance Ca2+-Activated K+ Channel in Glioblastoma GL-15 Cells , 2006, Cellular Physiology and Biochemistry.